Ignacio
Gil Bazo
Investigador hasta 2022
Memorial Sloan Kettering Cancer Center
Nueva York, Estados UnidosPublicaciones en colaboración con investigadores/as de Memorial Sloan Kettering Cancer Center (9)
2009
-
Factores ligados a angiogénesis, coagulación y fibrinólisis en el pronóstico de pacientes con cáncer colorectal
Salud(i)Ciencia, Vol. 16, Núm. 8, pp. 848-854
2007
-
Novel translational strategies in colorectal cancer research
World Journal of Gastroenterology, Vol. 13, Núm. 44, pp. 5902-5910
2006
-
Divulgación de los avances médicos: Una responsabilidad compartida
Medicina Clinica
-
New prognostic and predictive factors in advanced colorectal cancer
Medicina Clinica, Vol. 126, Núm. 14, pp. 541-548
-
Reassessment of Id1 protein expression in human mammary, prostate, and bladder cancers using a monospecific rabbit monoclonal anti-Id1 antibody
Cancer Research, Vol. 66, Núm. 22, pp. 10870-10877
2005
-
Erratum: Impact of surgery and chemotherapy on von Willebrand factor and vascular endothelial growth factor levels in colorectal cancer (Clin Transl Oncol (2005) 7:6 (270-1))
Clinical and Translational Oncology
-
Role of von Willebrand factor levels in the prognosis of stage IV colorectal cancer: Do we have enough evidence?
World Journal of Gastroenterology
-
Targeting hypoxia and angiogenesis through HIF-1α inhibition
Cancer Biology and Therapy, Vol. 4, Núm. 10, pp. 1055-1062
-
Update of the treatment of advanced prostate cancer and management of its complications
Medicina Clinica, Vol. 125, Núm. 17